Eye News and Research

Latest Eye News and Research

Bausch & Lomb's Lo-Torque- lens design delivers better rotational recovery

Bausch & Lomb today announced that the company's Lo-Torque- lens design demonstrates significantly better rotational recovery, which can lead to more consistent vision, compared with Acuvue's accelerated stabilization design. These findings from two clinical studies were presented at Academy 2009, the American Academy of Optometry annual meeting in Orlando, Fla.

13 Nov 2009

MSU team looks for characteristics of virtual workout partners to help improve physical fitness

Based on evidence people work harder with a partner than when working alone, a team of Michigan State University researchers are pairing college-age students with a virtual workout partner to study the impact on exercise trends.

13 Nov 2009

Contact lenses prescribed for longer replacement intervals can lead to undesirable clinical outcomes

Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear (stretching) that could lead to undesirable clinical effects, new research shows.

12 Nov 2009

First pediatric hospital to discharge child with mechanical heart assist device

Texas Children's Hospital is the nation's first pediatric hospital to discharge a child while on an intracorporeal ventricular assist device (VAD), a feat previously accomplished only at adult institutions. The patient, 16-year-old Francisco "Frank" De Santiago, who was implanted with a mechanical heart pump called the HeartMate II on May 19, 2009, was discharged on Oct. 29, 2009.

12 Nov 2009

MinuteClinic praises practitioners for providing affordable medical treatment and quality patient-centered care

In celebration of National Nurse Practitioner Week (Nov. 8-14), MinuteClinic, the pioneer and largest provider of retail health care centers in the United States, salutes practitioners across the country who deliver patient-centered care and help to increase access to high-quality, affordable medical treatment.

12 Nov 2009

Series of holiday cards to help build ORBIS Kids Sight treatment centres launched

ORBIS Canada, a non-profit global development organization dedicated to saving sight worldwide, is launching a series of holiday cards available for purchase this season. Proceeds of these cards will be used to build ORBIS Kids Sight treatment centres in the developing world.

12 Nov 2009

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Malfunctioning circadian clock genes may be responsible for bipolar disorder in children. Researchers writing in the open access journal BMC Psychiatry found four versions of the regulatory gene RORB that were associated with pediatric bipolar disorder.

11 Nov 2009

Glissandra Skincare launches three signature anti-aging products

Glissandra™ Skincare Inc. announced the global launch of its three signature anti-aging products concurrent with the Israel Cancer Research Fund’s “Women of Action” awards luncheon honoring Beverly Cohen, Lisi Harrison, and Vivien Zighelboim, Ph.D, at the Four Seasons Hotel, Los Angeles at Beverly Hills.

11 Nov 2009

Global Health partners with Eira Hospital to start obesity treatment operations in Finland

In collaboration with Eira Hospital in Helsinki, Global Health Partner (STO:GHP) has started up obesity treatment operations and the first bariatric surgery procedure has now been performed. Finland has the highest obesity prevalence in the Nordic countries. However, the number of bariatric surgery procedures has so far been very low. “We see Finland as a very exciting market with great potential and are happy to be doing this in collaboration with the well-reputed Eira Hospital,” says Per Båtelson, Global Health Partner’s CEO.

11 Nov 2009

$9M ARRA funds to reduce healthcare-associated infections in ambulatory surgical centers

To reduce healthcare-associated infections (HAIs) in stand-alone or same-day surgical centers, the HHS Secretary Kathleen Sebelius today announced the availability of up to $9 million in funding from the American Recovery and Reinvestment Act (ARRA) to state survey agencies in 43 states. HAIs are infections some patients acquire when they are in a health care setting such as a hospital or outpatient clinic.

11 Nov 2009

Handbook for rural health care ethics

With an eye to small-town health professionals as well as to the people training students to practice medicine beyond metropolitan settings, Dartmouth's Department of Community and Family Medicine is unveiling the Handbook for Rural Health Care Ethics.

11 Nov 2009

Tel Aviv University develops innovative algorithms to combat Intra-uterine growth restrictions for healthy babies

When a fetus is smaller than expected for the number of weeks of pregnancy, due to associated problems like a poorly developed heart, health concerns as severe as brain damage can result.

11 Nov 2009

Children with autism have slower pupil responses to light change: Study

Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.

11 Nov 2009

Medicare Advantage plans are largely unpopular in rural states

Kansas Health Institute examines Medicare Advantage plans, which are less popular in rural areas, in a series of reports.

11 Nov 2009

Colorcon acquires exclusive rights to market ARmark's micro-tag authentication technology

ARmark Authentication Technologies, LLC, and Colorcon, Inc. announced today an alliance in the development and introduction of ®mark® On-Dose ID(TM), an authentication technology that incorporates microscopic covert micro-tags into the immediate-release film coatings of solid oral dosage forms (SODFs) to prevent counterfeiting.

10 Nov 2009

Goethe University professors discuss cataract surgery and artificial lens implantation

As many as 10 million people around the world suffer from cataracts. Thomas Kohnen of the Goethe University in Frankfurt and his coauthors discuss cataract surgery with the implantation of an artificial lens in the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2009; 106[43]: 695).

10 Nov 2009

House-passed abortion restrictions could stir up Senate's health reform debate

The Washington Post: "The abortion issue had been rumbling within the House Democratic caucus for weeks, but Saturday's votes revealed the depths of the fault lines. The amendment passed with the support of 64 Democrats, roughly a quarter of the party caucus." And with an eye on the Senate and eventual conference committee negotiations, abortion-rights supporters are now pledging to strip the amendment out of the underlying health bill.

10 Nov 2009

FDA's approval time for medical devices increases

According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.

7 Nov 2009

Pediatrician recommends red reflex vision test for all newborns

With the number of premature births and medically fragile infants now increasing in the U.S., a basic eye exam, including a red reflex test, should be given to all children shortly after birth, reports Angela Buffenn, M.D., M.P.H., Director of the Orbit and Eye Movement Institute at The Vision Center of Childrens Hospital Los Angeles.

7 Nov 2009

Rituximab drug potentially effective for treating Graves' eye disease, shows study

A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms - and improved vision - following treatment with the drug rituximab. Inflammation around their eyes and damage to the optic nerve were significantly reduced. The same patients had not previously responded to steroids, a common treatment for Graves' eye disease.

7 Nov 2009

Eye News and Research

Latest Eye News and Research

Bausch & Lomb's Lo-Torque- lens design delivers better rotational recovery

MSU team looks for characteristics of virtual workout partners to help improve physical fitness

Contact lenses prescribed for longer replacement intervals can lead to undesirable clinical outcomes

First pediatric hospital to discharge child with mechanical heart assist device

MinuteClinic praises practitioners for providing affordable medical treatment and quality patient-centered care

Series of holiday cards to help build ORBIS Kids Sight treatment centres launched

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Glissandra Skincare launches three signature anti-aging products

Global Health partners with Eira Hospital to start obesity treatment operations in Finland

$9M ARRA funds to reduce healthcare-associated infections in ambulatory surgical centers

Handbook for rural health care ethics

Tel Aviv University develops innovative algorithms to combat Intra-uterine growth restrictions for healthy babies

Children with autism have slower pupil responses to light change: Study

Medicare Advantage plans are largely unpopular in rural states

Colorcon acquires exclusive rights to market ARmark's micro-tag authentication technology

Goethe University professors discuss cataract surgery and artificial lens implantation

House-passed abortion restrictions could stir up Senate's health reform debate

FDA's approval time for medical devices increases

Pediatrician recommends red reflex vision test for all newborns

Rituximab drug potentially effective for treating Graves' eye disease, shows study

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Eye News and Research

Latest Eye News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in